Compare Abbott India with WYETH - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WYETH - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WYETH 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WYETH ABBOTT INDIA/
WYETH
 
P/E (TTM) x 48.3 27.7 174.3% View Chart
P/BV x 15.6 5.3 291.9% View Chart
Dividend Yield % 0.4 1.3 34.6%  

Financials

 ABBOTT INDIA   WYETH
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
WYETH
Mar-13
ABBOTT INDIA/
WYETH
5-Yr Chart
Click to enlarge
High Rs8,8341,044 845.9%   
Low Rs5,458818 667.2%   
Sales per share (Unadj.) Rs1,731.1298.6 579.8%  
Earnings per share (Unadj.) Rs211.957.2 370.2%  
Cash flow per share (Unadj.) Rs219.958.4 376.4%  
Dividends per share (Unadj.) Rs65.0017.00 382.4%  
Dividend yield (eoy) %0.91.8 49.8%  
Book value per share (Unadj.) Rs945.2249.5 378.9%  
Shares outstanding (eoy) m21.2522.72 93.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.1 132.3%   
Avg P/E ratio x33.716.3 207.3%  
P/CF ratio (eoy) x32.515.9 203.9%  
Price / Book Value ratio x7.63.7 202.5%  
Dividend payout %30.729.7 103.3%   
Avg Mkt Cap Rs m151,84821,157 717.7%   
No. of employees `0003.50.5 708.3%   
Total wages/salary Rs m4,356400 1,089.0%   
Avg. sales/employee Rs Th10,555.513,787.4 76.6%   
Avg. wages/employee Rs Th1,249.9813.0 153.7%   
Avg. net profit/employee Rs Th1,292.22,643.3 48.9%   
INCOME DATA
Net Sales Rs m36,7866,783 542.3%  
Other income Rs m1,133353 321.3%   
Total revenues Rs m37,9197,136 531.4%   
Gross profit Rs m6,0471,617 373.9%  
Depreciation Rs m16927 636.1%   
Interest Rs m236 409.1%   
Profit before tax Rs m6,9891,938 360.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m2,485632 393.1%   
Profit after tax Rs m4,5031,301 346.3%  
Gross profit margin %16.423.8 69.0%  
Effective tax rate %35.632.6 109.0%   
Net profit margin %12.219.2 63.9%  
BALANCE SHEET DATA
Current assets Rs m27,6106,984 395.3%   
Current liabilities Rs m8,5692,056 416.8%   
Net working cap to sales %51.872.6 71.2%  
Current ratio x3.23.4 94.9%  
Inventory Days Days6099 60.7%  
Debtors Days Days2724 114.4%  
Net fixed assets Rs m1,057244 432.6%   
Share capital Rs m213227 93.5%   
"Free" reserves Rs m19,8735,441 365.3%   
Net worth Rs m20,0865,668 354.4%   
Long term debt Rs m025 0.0%   
Total assets Rs m29,4097,901 372.2%  
Interest coverage x311.6353.3 88.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.9 145.7%   
Return on assets %15.416.5 93.1%  
Return on equity %22.422.9 97.7%  
Return on capital %34.934.0 102.5%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m36915 2,427.4%   
Fx outflow Rs m4,9182,677 183.7%   
Net fx Rs m-4,549-2,662 170.9%   
CASH FLOW
From Operations Rs m4,991923 540.7%  
From Investments Rs m-2,570317 -811.0%  
From Financial Activity Rs m-1,428-481 296.9%  
Net Cashflow Rs m993759 130.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 7.2 1.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 30.4 56.3%  
Shareholders   18,270 21,978 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ELDER PHARMA  FDC  WOCKHARDT  GSK PHARMA  DR. DATSONS LABS  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Mar 5, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ORCHID PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS